SlideShare a Scribd company logo
1 of 26
Antibodies as Drugs Lauren Lahey April 26, 2007
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Emerging Themes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
At the turn of the 20 th  century: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
More recently: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Important Terms ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Structure of an Antibody ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Formation of Disulfide Bonds ,[object Object],[object Object],[object Object],[object Object]
Compliment fixation First antibody secreted in development μ IgM Promotes antibody-dependent cellular cytotoxicity (ADCC)  Compliment fixation Main antibody in serum Most Stable γ IgG Cells that secrete histamines ε IgE B Cell surface receptor δ IgD External Secretions or α IgA Biological Activity Distribution Diagram Heavy Chain Immunoglobulin   (Ig) Class
Hypervariable Loops  ,[object Object],[object Object],[object Object],[object Object],[object Object]
A Dynamic Binding Site ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antibody Pharmokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cross-linking ,[object Object],[object Object],[object Object],[object Object]
Mechanisms of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
“Humanizing” Antibodies ,[object Object],[object Object],[object Object],[object Object],[object Object]
Production of Human Antibodies
Pharmaceutical Antibodies ,[object Object],[object Object],[object Object],[object Object],[object Object]
Nomenclature of Monoclonal Antibodies toxin as target -tox(a)- nervous system -neu(r)- miscellaneous tumor -tu(m)- prostate tumor -pr(o)- ovarian tumor -go(v)- testicular tumor -go(t)- mammary tumor -ma(r)- melanoma -me(l)- colonic tumor -co(l)- rat/murine hybrid -axo- interleukin -ki(n)- humanized -zu- musculoskeletal -mu(l)- chimeric -xi- cardiovascular -ci(r)- primate -i- infectious lesions -le(s)- hamster -e- immune -li(m)- rat -a- bacterial -ba(c)- mouse -o- viral -vi(r)- -mab human -u- bone -o(s)- variable Suffix Source Target Prefix
Autoimmune Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rheumatoid Arthritis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infliximab ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adalimumab ,[object Object],[object Object],[object Object],[object Object],[object Object]
Rituximab ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Interesting Variations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Nanobodies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Humoral immune response
Humoral immune responseHumoral immune response
Humoral immune response
sufihannan
 
MONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIESMONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIES
Umair hanif
 

What's hot (20)

Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Introduction to antigen
Introduction to  antigenIntroduction to  antigen
Introduction to antigen
 
Humoral immune response
Humoral immune responseHumoral immune response
Humoral immune response
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Immunity. Basic princeples of humoral and cellular immune response.
Immunity. Basic princeples of humoral and cellular immune response. Immunity. Basic princeples of humoral and cellular immune response.
Immunity. Basic princeples of humoral and cellular immune response.
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
 
MONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIESMONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIES
 
MHC
MHC MHC
MHC
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibody
 
Monoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal AntibodiesMonoclonal and Polyclonal Antibodies
Monoclonal and Polyclonal Antibodies
 
Antigen
AntigenAntigen
Antigen
 
Molecular mimicry
Molecular mimicryMolecular mimicry
Molecular mimicry
 
Antigen
AntigenAntigen
Antigen
 
Evasion Mechanism By Virus
Evasion Mechanism By VirusEvasion Mechanism By Virus
Evasion Mechanism By Virus
 
Active and passive immunity
Active and passive immunityActive and passive immunity
Active and passive immunity
 
Antigen
AntigenAntigen
Antigen
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Antibodies, vaccines, adjuvents
Antibodies, vaccines, adjuventsAntibodies, vaccines, adjuvents
Antibodies, vaccines, adjuvents
 

Viewers also liked (8)

Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Antibodies Productions
Antibodies ProductionsAntibodies Productions
Antibodies Productions
 
Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology  Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology
 
Immunoglobulins, complement and immunodefeciency disorders
Immunoglobulins, complement and immunodefeciency disordersImmunoglobulins, complement and immunodefeciency disorders
Immunoglobulins, complement and immunodefeciency disorders
 
Monoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical SignificanceMonoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical Significance
 
Immunoglobulins
ImmunoglobulinsImmunoglobulins
Immunoglobulins
 
Slideshare ppt
Slideshare pptSlideshare ppt
Slideshare ppt
 

Similar to Antibodies as Drugs

monoclonal antibodies and engineered antibodies
monoclonal antibodies and engineered antibodiesmonoclonal antibodies and engineered antibodies
monoclonal antibodies and engineered antibodies
Munawar Ali
 
Monoclonal antibodies anticancer therapy[1] (1)
Monoclonal antibodies anticancer therapy[1] (1)Monoclonal antibodies anticancer therapy[1] (1)
Monoclonal antibodies anticancer therapy[1] (1)
Asma Kilani
 
Monoclonal Antibodies As Therapeutic Agents In Oncology And
Monoclonal Antibodies As Therapeutic Agents In Oncology AndMonoclonal Antibodies As Therapeutic Agents In Oncology And
Monoclonal Antibodies As Therapeutic Agents In Oncology And
drmisbah83
 

Similar to Antibodies as Drugs (20)

Monoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progressMonoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progress
 
Monoclonal Antibodies
Monoclonal Antibodies Monoclonal Antibodies
Monoclonal Antibodies
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody Engineering
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Therapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammationTherapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammation
 
monoclonal antibodies and engineered antibodies
monoclonal antibodies and engineered antibodiesmonoclonal antibodies and engineered antibodies
monoclonal antibodies and engineered antibodies
 
Antibody&antigen faq
Antibody&antigen faq Antibody&antigen faq
Antibody&antigen faq
 
mAb
mAbmAb
mAb
 
Production of monoclonal antibodies and applications in therapy and diagnosis
Production of monoclonal antibodies and applications in therapy and diagnosisProduction of monoclonal antibodies and applications in therapy and diagnosis
Production of monoclonal antibodies and applications in therapy and diagnosis
 
Antibody humanization techniques
Antibody humanization techniquesAntibody humanization techniques
Antibody humanization techniques
 
Hybridoma technology mukesh
Hybridoma technology mukeshHybridoma technology mukesh
Hybridoma technology mukesh
 
Anti cancer therapy
Anti cancer therapyAnti cancer therapy
Anti cancer therapy
 
MONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIESMONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODIES
 
Novel Strategies for the Delivery of Antimicrobial Compounds into Bacterial C...
Novel Strategies for the Delivery of Antimicrobial Compounds into Bacterial C...Novel Strategies for the Delivery of Antimicrobial Compounds into Bacterial C...
Novel Strategies for the Delivery of Antimicrobial Compounds into Bacterial C...
 
Monoclonal antibodies anticancer therapy[1] (1)
Monoclonal antibodies anticancer therapy[1] (1)Monoclonal antibodies anticancer therapy[1] (1)
Monoclonal antibodies anticancer therapy[1] (1)
 
antibiotics
antibioticsantibiotics
antibiotics
 
2062.pptx
2062.pptx2062.pptx
2062.pptx
 
Monoclonal Antibodies As Therapeutic Agents In Oncology And
Monoclonal Antibodies As Therapeutic Agents In Oncology AndMonoclonal Antibodies As Therapeutic Agents In Oncology And
Monoclonal Antibodies As Therapeutic Agents In Oncology And
 
Monoclonal antibody ppt
Monoclonal antibody pptMonoclonal antibody ppt
Monoclonal antibody ppt
 
Jimmy
JimmyJimmy
Jimmy
 

More from Flavio Guzmán (20)

Ops
OpsOps
Ops
 
Pk2
Pk2Pk2
Pk2
 
Pk2
Pk2Pk2
Pk2
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Pk1 Ppt
Pk1 PptPk1 Ppt
Pk1 Ppt
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Ceorins
CeorinsCeorins
Ceorins
 
AUPDATE
AUPDATEAUPDATE
AUPDATE
 
05052008OvarianTelehealth
05052008OvarianTelehealth05052008OvarianTelehealth
05052008OvarianTelehealth
 
mati
matimati
mati
 
DrTerespolsky
DrTerespolskyDrTerespolsky
DrTerespolsky
 
15
1515
15
 
gopalan031607
gopalan031607gopalan031607
gopalan031607
 
IncidentalomaTalk
IncidentalomaTalkIncidentalomaTalk
IncidentalomaTalk
 
Nikiforov
NikiforovNikiforov
Nikiforov
 
Thpt
ThptThpt
Thpt
 
Thyroid Disease
Thyroid DiseaseThyroid Disease
Thyroid Disease
 
THYCER
THYCERTHYCER
THYCER
 
DrRobertFoxUtahSSF
DrRobertFoxUtahSSFDrRobertFoxUtahSSF
DrRobertFoxUtahSSF
 
Sjögren's_syndrome~_Role_for_Cevimeline
Sjögren's_syndrome~_Role_for_CevimelineSjögren's_syndrome~_Role_for_Cevimeline
Sjögren's_syndrome~_Role_for_Cevimeline
 

Recently uploaded

CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
giselly40
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
Enterprise Knowledge
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
Earley Information Science
 

Recently uploaded (20)

CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
Boost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityBoost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivity
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 

Antibodies as Drugs

  • 1. Antibodies as Drugs Lauren Lahey April 26, 2007
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Compliment fixation First antibody secreted in development μ IgM Promotes antibody-dependent cellular cytotoxicity (ADCC) Compliment fixation Main antibody in serum Most Stable γ IgG Cells that secrete histamines ε IgE B Cell surface receptor δ IgD External Secretions or α IgA Biological Activity Distribution Diagram Heavy Chain Immunoglobulin (Ig) Class
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Production of Human Antibodies
  • 17.
  • 18. Nomenclature of Monoclonal Antibodies toxin as target -tox(a)- nervous system -neu(r)- miscellaneous tumor -tu(m)- prostate tumor -pr(o)- ovarian tumor -go(v)- testicular tumor -go(t)- mammary tumor -ma(r)- melanoma -me(l)- colonic tumor -co(l)- rat/murine hybrid -axo- interleukin -ki(n)- humanized -zu- musculoskeletal -mu(l)- chimeric -xi- cardiovascular -ci(r)- primate -i- infectious lesions -le(s)- hamster -e- immune -li(m)- rat -a- bacterial -ba(c)- mouse -o- viral -vi(r)- -mab human -u- bone -o(s)- variable Suffix Source Target Prefix
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.